Unveiling Metabolic Phenotype Alterations in Anorexia Nervosa through Metabolomics.
Laura Mayo-MartínezFrancisco Javier RupérezGabriel Ángel Martos-MorenoMontserrat GraellCoral BarbasJesús ArgenteAntonia GarcíaPublished in: Nutrients (2021)
Anorexia nervosa (AN) is a mental disorder characterized by an intense fear of weight gain that affects mainly young women. It courses with a negative body image leading to altered eating behaviors that have devastating physical, metabolic, and psychological consequences for the patients. Although its origin is postulated to be multifactorial, the etiology of AN remains unknown, and this increases the likelihood of chronification and relapsing. Thus, expanding the available knowledge on the pathophysiology of AN is of enormous interest. Metabolomics is proposed as a powerful tool for the elucidation of disease mechanisms and to provide new insights into the diagnosis, treatment, and prognosis of AN. A review of the literature related to studies of AN patients by employing metabolomic strategies to characterize the main alterations associated with the metabolic phenotype of AN during the last 10 years is described. The most common metabolic alterations are derived from chronic starvation, including amino acid, lipid, and carbohydrate disturbances. Nonetheless, recent findings have shifted the attention to gut-microbiota metabolites as possible factors contributing to AN development, progression, and maintenance. We have identified the areas of ongoing research in AN and propose further perspectives to improve our knowledge and understanding of this disease.
Keyphrases
- anorexia nervosa
- end stage renal disease
- weight gain
- ejection fraction
- newly diagnosed
- chronic kidney disease
- mass spectrometry
- mental health
- physical activity
- peritoneal dialysis
- rheumatoid arthritis
- patient reported outcomes
- depressive symptoms
- working memory
- systemic lupus erythematosus
- fatty acid
- replacement therapy
- drug induced
- gestational age